Sorafenib (Nexavar®) induces molecular remission and regression of extramedullary disease in a patient with FLT3-ITD+ acute myeloid leukemia - Concepedia

Concepedia

Publication | Closed Access

Sorafenib (Nexavar®) induces molecular remission and regression of extramedullary disease in a patient with FLT3-ITD+ acute myeloid leukemia

75

Citations

4

References

2008

Year

Nancy Safaian, Akos Czibere, Ingmar Bruns, Roland Fenk, P. Reinecke, Ariane Dienst, Rainer Haas, Guido Kobbe

Leukemia Research

Hematological MalignancyExtramedullary DiseaseMolecular RemissionMedicineImmunologyHematologyPathologyPharmacotherapyOncologyMolecular MedicineMyeloid Neoplasia

References

	Year	Citations

Page 1

Page 1